Clinical Trial Detail

NCT ID NCT02993731
Title A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma (CanStem111P)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boston Biomedical, Inc

pancreatic ductal adenocarcinoma


Gemcitabine + Nab-paclitaxel + Napabucasin

Gemcitabine + Nab-paclitaxel

Age Groups: adult senior

No variant requirements are available.